Artificial intelligence meets the world experts; updates and novel therapies in autoimmunity - The 14th international congress on autoimmunity 2024 (AUTO14), Ljubljana

Autoimmun Rev. 2025 Jan 3;24(1):103698. doi: 10.1016/j.autrev.2024.103698. Epub 2024 Nov 20.

Abstract

The bi-annual international congress on autoimmunity is a huge opportunity for the medical community to discuss the latest updates in the field. During the 14th congress 2024 (AUTO14) in Ljubljana, artificial intelligence (AI) occupied special attention due to its recent and ongoing unequivocal role in various medical fields including autoimmunity. For instance, through a challenging debate between world-experts and the most popular AI bot used (ChatGPT), several clinical cases including a case of vasculitis were discussed in the plenary sessions. ChatGPT agreed with the clinical decisions made by the experts nevertheless, the bot added additional aspects related to the specific case. In this regard, ChatGPT emphasized the need for osteoporosis prophylaxis in a patient planned to be treated with systemic steroids for a long time. Furthermore, AUTO14 included the newest updates on most autoimmune disorders, distributed among tens of sessions. Among others, infection and autoimmunity, the sequalae of the pandemic of COVID-19, as well as COVID-19 vaccines were discussed as well. Due to the high numbers of the works presented, and for ensuring that important updates are not missed; we divided our paper into sections. The subtitles throughout the paper correspond to different sessions of the congress, all presenting new updates in the field. A figure aiding in navigating throughout the paper was also provided.

Keywords: AUTO14; Artificial intelligence; Autoantibodies; Autoimmunity; ChatGPT.

Publication types

  • Congress
  • Review

MeSH terms

  • Artificial Intelligence*
  • Autoimmune Diseases* / immunology
  • Autoimmune Diseases* / therapy
  • Autoimmunity*
  • COVID-19 Vaccines / immunology
  • COVID-19 Vaccines / therapeutic use
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • Congresses as Topic
  • Humans
  • SARS-CoV-2 / immunology

Substances

  • COVID-19 Vaccines